Cisco raises annual resulsts forecast fueled by AI demand | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]The logo of networking gear maker Cisco Systems Inc is seen during GSMA's 2022 Mobile World Congress (MWC) in Barcelona, Spain February 28, 2022. REUTERS/Nacho Doce [Purchase Licensing Rights, opens new tab]Feb 11 (Reuters) - Cisco Systems [(CSCO.O), opens new tab] raised its full-year revenue and adjusted profit forecasts on W ...

McDonald's beats quarterly global sales estimates as value bets pay off | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]McDonald's logo is seen in this illustration taken August 5, 2025. REUTERS/Dado Ruvic/Illustration [Purchase Licensing Rights, opens new tab]- Companies- Summary- McDonald's value promotions attract budget-conscious US diners- Revenue jumps 10% to $7.01 billion- Q4 global same-store sales rise 5.7%, beating 3.7% e ...

Core Insights - ANZ Group reported a 17% increase in cash profit for Q1, driven by lower costs, stronger revenue, and improved cash returns on equity [1] - Cash profit for the three months ending December 31 was A$1.94 billion ($1.38 billion), while statutory profit was A$1.87 billion [1] - The common equity tier 1 (CET1) ratio improved to 12.15% as of December 31, up from 12% on September 30 [1] Financial Performance - The bank's return on shareholders' tangible equity rose by 1.73 percentage points to 11.7% [1] - Portfolio losses remained low, indicating strong credit quality, with non-performing exposures at 0.78% [1] Market Context - The overall credit quality and customer resilience were noted to be strong under lower interest rates and unemployment [1]

Core Viewpoint - Pershing Square Capital Management, led by Bill Ackman, has invested approximately $2 billion in Meta Platforms, anticipating significant long-term benefits from artificial intelligence (AI) despite recent stock price declines [1][1]. Investment Strategy - The hedge fund allocated about 10% of its capital to the Meta investment, indicating a strong belief in the company's undervalued potential [1]. - Ackman’s team noted that Meta's stock has increased by 11% in 2025 and 3% in 2026 through February 9, despite a 7.4% decline over the past year [1][1]. AI Initiatives - Concerns regarding Meta's spending on AI initiatives have affected its stock performance, but the investment team believes AI will enhance content recommendations and personalized advertising, potentially increasing user engagement through AI-driven tools [1][1]. Market Position - Ackman has shown interest in major technology companies, having previously invested in Amazon and Alphabet, positioning Pershing Square as a significant player in the tech investment landscape [1][1].

Core Viewpoint - Northrop Grumman and Polish arms maker Niewiadow-PGM plan to produce over 180,000 artillery shells annually in Poland, targeting the U.S., Polish, and broader European markets, with potential sales to Ukraine [1]. Group 1: Production Plans - The companies have signed a framework deal to jointly produce 155-mm ammunition, with production expected to start within the year [1]. - Northrop Grumman's managing director for Poland indicated that the technology they possess can support the targeted production volume of 180,000 shells per year [1]. Group 2: Technological Advancements - The collaboration will advance Northrop Grumman's Austempered Ductile Iron (ADI) technology, which allows for cheaper and faster production processes compared to traditional methods [1]. - As the ADI technology matures, Northrop Grumman anticipates significant scaling of production capacity [1]. Group 3: Strategic Importance - Poland is viewed as a strategic location for Northrop Grumman due to its increasing defense spending, projected to be 4.8% of its GDP this year, and its importance from both security and industrial perspectives [1]. - The company is also in advanced discussions with Polish state-controlled ammunition maker Mesko for co-production of 30-mm and 120-mm rounds [1].

US Fed to review previously flagged bank shortcomings, memo says | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]Cranes loom over the construction site of the Federal Reserve headquarters amid renovations of the building, in Washington, D.C., U.S., January 12, 2026. REUTERS/Kevin Lamarque/File Photo [Purchase Licensing Rights, opens new tab]Feb 11 (Reuters) - The Federal Reserve plans to review all issues its examiners had previous ...

Top Democrat on US House China committee open to Nvidia H200 sales | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]Item 1 of 2 U.S. Representative Ro Khanna (D-CA) speaks during a press conference on the Epstein Files Transparency Act ahead of a House vote on the release of files related to the late convicted sex offender Jeffrey Epstein, on Capitol Hill in Washington, D.C., U.S., November 18, 2025. REUTERS/Annabelle Gordon[1/2]U.S ...

Core Viewpoint - SOLV Energy's shares increased by 20% during its New York debut, achieving a valuation of $5.98 billion, indicating a robust recovery in IPO activity for 2026 [1] Company Summary - SOLV Energy specializes in solar and battery storage solutions, reflecting a growing interest in renewable energy sectors [1] Industry Summary - The significant rise in SOLV Energy's stock price highlights a broader trend of revitalization in the IPO market, particularly in the renewable energy industry [1]

Core Insights - A study by Truveta reveals that 36% of early users of Novo Nordisk's Wegovy weight-loss pill are new to GLP-1 medications, indicating a significant market expansion for the drug [1] - Among patients who started a new prescription for Wegovy, 21.1% had previously used the injectable version of Wegovy, while 15.8% switched from Eli Lilly's Zepbound, another GLP-1 injectable [1] Company Analysis - Novo Nordisk's Wegovy pill was approved by the U.S. Food and Drug Administration on December 22, marking a pivotal moment for the company in the weight-loss medication market [1] - The data suggests that Wegovy is attracting a new demographic of patients who have not previously used GLP-1 drugs, which could lead to increased sales and market share for Novo Nordisk [1] Industry Implications - The findings indicate a growing acceptance and demand for GLP-1 medications in the weight-loss sector, potentially influencing competitive dynamics among pharmaceutical companies [1] - The shift from injectable to oral forms of GLP-1 drugs may reshape patient preferences and treatment protocols within the industry [1]

Core Insights - Meta is investing $10 billion in a new data center in Indiana to enhance its computing power for artificial intelligence applications [1] Company Developments - The new data center is part of Meta's strategy to secure the necessary infrastructure to support its growing AI initiatives [1]